Boiron SA (LON:0DTF)

Market Cap	449.94M +18.2%
Revenue (ttm)	432.76M +4.8%
Net Income	16.60M -18.2%
EPS	0.96 -18.2%
Shares Out	n/a
PE Ratio	27.10
Forward PE	18.95
Dividend	1.01 (3.43%)
Ex-Dividend Date	Jun 3, 2025

Volume	151
Average Volume	21
Open	29.85
Previous Close	29.50
Day's Range	28.50 - 29.85
52-Week Range	21.10 - 31.25
Beta	0.30
RSI	48.48
Earnings Date	Mar 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1932
• Employees: 2,736
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DTF

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.

Financial numbers in EUR